Lyra Therapeutics, Inc. (LYRA)
0.19
0.00 (0.00%)
USD |
OTCM |
Oct 14, 16:00
Lyra Therapeutics Shareholders Equity (Quarterly) : -10.72M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | -10.72M |
| September 30, 2025 | -4.328M |
| June 30, 2025 | 1.622M |
| March 31, 2025 | 3.872M |
| December 31, 2024 | 11.59M |
| September 30, 2024 | 20.62M |
| June 30, 2024 | 30.98M |
| March 31, 2024 | 77.50M |
| December 31, 2023 | 89.42M |
| September 30, 2023 | 84.24M |
| June 30, 2023 | 98.58M |
| March 31, 2023 | 66.09M |
| December 31, 2022 | 80.75M |
| Date | Value |
|---|---|
| September 30, 2022 | 93.22M |
| June 30, 2022 | 106.25M |
| March 31, 2022 | 23.26M |
| December 31, 2021 | 34.32M |
| September 30, 2021 | 47.19M |
| June 30, 2021 | 57.50M |
| March 31, 2021 | 67.55M |
| December 31, 2020 | 74.49M |
| September 30, 2020 | 80.91M |
| June 30, 2020 | 86.82M |
| March 31, 2020 | 33.42M |
| December 31, 2019 | 7.328M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | 63.61M |
| CorMedix, Inc. | 460.83M |
| Eloxx Pharmaceuticals, Inc. | 46.42M |
| Breakthrough Chemistry, Inc. | 0.8373M |
| BioStem Technologies, Inc. | 27.61M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 36.11M |
| Total Liabilities (Quarterly) | 46.82M |
| Debt to Equity Ratio | -2.824 |
| Current Ratio | 1.709 |
| Net Debt Paydown Yield | 18.53% |